{"id":661,"date":"2021-06-02T12:50:41","date_gmt":"2021-06-02T09:50:41","guid":{"rendered":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/?page_id=661"},"modified":"2025-01-17T12:02:41","modified_gmt":"2025-01-17T10:02:41","slug":"sarka-lehtonen","status":"publish","type":"page","link":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/","title":{"rendered":"\u0160\u00e1rka Lehtonen"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-1024x683.jpg\" alt=\"\" class=\"wp-image-113\" srcset=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-1024x683.jpg 1024w, https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-300x200.jpg 300w, https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-768x512.jpg 768w, https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-1536x1024.jpg 1536w, https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p style=\"font-size:18px\">PhD Pharm., Research Director.<\/p>\n\n\n\n<p><strong>Academic degrees:<\/strong>\u200b<br>Adjunct Professor in Neuropharmacology, UEF, 2016\u200b<br>PhD Pharm (Pharmacology), University of Kuopio, 2005\u200b<br>MSc Pharm (Pharmacology), Charles University in Prague, 1999<\/p>\n\n\n\n<p style=\"font-size:18px\"><strong>Major positions and appointments:<\/strong>\u200b<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Research Director,&nbsp;A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, 2024-<\/li>\n\n\n\n<li>Sigrid<strong>&nbsp;<\/strong>Jus\u00e9lius Research Fellow, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, 2021\u200b-2024<\/li>\n\n\n\n<li>Senior researcher, Neuroscience Center, HiLIFE, University of Helsinki, 2018-\u200b<\/li>\n\n\n\n<li>University researcher, Saastamoinen s\u00e4\u00e4ti\u00f6 Fellowship, University of Eastern&nbsp;Finland, 2013-2016\u200b<\/li>\n\n\n\n<li>Visiting researcher, Faculty of Medicine, Department of Stem Cell Biology, Masaryk University, Brno, 2012-2013\u200b<\/li>\n\n\n\n<li>Assistant in Pharmacology, Department of Pharmacology and Toxicology, University of Kuopio, 2007-2011\u200b<\/li>\n\n\n\n<li>Postdoctoral researcher, Faculty of Medicine, Department of Pharmacology, University of Helsinki, 2005-2007\u200b<\/li>\n\n\n\n<li>PhD student, Department of Pharmacology and Toxicology, University of Kuopio, 2001-2005\u200b<\/li>\n<\/ul>\n\n\n\n<p style=\"font-size:18px\"><strong>Teaching<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Supervision of PhD, MSc, BSc., medical trainees, ERASMUS and EDUFI students<\/li>\n\n\n\n<li>Course coordinator \u2013 Regenerative medicine (5 ECTS), taught yearly at the UEF (Biomedicine) during the autumn semester<\/li>\n\n\n\n<li>Broad experience of teaching in various courses of pharmacology, neuroscience and stem cell biology&nbsp;<\/li>\n<\/ul>\n\n\n\n<p style=\"font-size:18px\"><strong>The lab is&nbsp;funded by<\/strong>\u200b\u200b:<\/p>\n\n\n    <div class=\"funders grid\">\n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/WATER_RC_logo_saastamoisen_saatio-kopio_0.jpg\" alt=\"The logo of Saastamoisen s\u00e4\u00e4ti\u00f6\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/skr_vihrea_cmyk.jpg\" alt=\"The logo of Suomen kulttuurirahasto\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/Parkinson_logo_Eng.png\" alt=\"The logo of Suomen Parkinson-s\u00e4\u00e4ti\u00f6\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/bf_logo.jpg\" alt=\"The logo of Business Finland\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/Capture.png\" alt=\"The logo of Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/logo-saatio_black_sakari.png\" alt=\"The logo of Sakari Sohlbergin s\u00e4\u00e4ti\u00f6\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/orion-logo.png\" alt=\"The logo of Orion\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/06\/jja-erkko-saatio.jpg\" alt=\"The logo of Jane ja Aatos Erkon s\u00e4\u00e4ti\u00f6\" \/>\n                <\/div>\n                                                <\/div>\n                        \n                        <div class=\"funders__item grid__item\">\n                            <div class=\"funders__image\">\n                    <img decoding=\"async\" src=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2022\/06\/logo.jpg\" alt=\"The logo of Young Universities for the Future of Europe\" \/>\n                <\/div>\n                                                <\/div>\n                        \n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>PhD Pharm., Research Director. Academic degrees:\u200bAdjunct Professor in Neuropharmacology, UEF, 2016\u200bPhD Pharm (Pharmacology), University of Kuopio, 2005\u200bMSc Pharm (Pharmacology), Charles University in Prague, 1999 Major positions and appointments:\u200b Teaching: The lab is&nbsp;funded by\u200b\u200b:<\/p>\n","protected":false},"author":575,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-661","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group\" \/>\n<meta property=\"og:description\" content=\"PhD Pharm., Research Director. Academic degrees:\u200bAdjunct Professor in Neuropharmacology, UEF, 2016\u200bPhD Pharm (Pharmacology), University of Kuopio, 2005\u200bMSc Pharm (Pharmacology), Charles University in Prague, 1999 Major positions and appointments:\u200b Teaching: The lab is&nbsp;funded by\u200b\u200b:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/\" \/>\n<meta property=\"og:site_name\" content=\"Lehtonen lab\/ Human Brain Disease Modelling Research Group\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-17T10:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/\",\"url\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/\",\"name\":\"\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group\",\"isPartOf\":{\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-1024x683.jpg\",\"datePublished\":\"2021-06-02T09:50:41+00:00\",\"dateModified\":\"2025-01-17T10:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage\",\"url\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg\",\"contentUrl\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"Lehtonen Sarka\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u0160\u00e1rka Lehtonen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/#website\",\"url\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/\",\"name\":\"Lehtonen lab\/ Human Brain Disease Modelling Research Group\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/","og_locale":"en_US","og_type":"article","og_title":"\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group","og_description":"PhD Pharm., Research Director. Academic degrees:\u200bAdjunct Professor in Neuropharmacology, UEF, 2016\u200bPhD Pharm (Pharmacology), University of Kuopio, 2005\u200bMSc Pharm (Pharmacology), Charles University in Prague, 1999 Major positions and appointments:\u200b Teaching: The lab is&nbsp;funded by\u200b\u200b:","og_url":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/","og_site_name":"Lehtonen lab\/ Human Brain Disease Modelling Research Group","article_modified_time":"2025-01-17T10:02:41+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/","url":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/","name":"\u0160\u00e1rka Lehtonen - Lehtonen lab\/ Human Brain Disease Modelling Research Group","isPartOf":{"@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage"},"image":{"@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage"},"thumbnailUrl":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-1024x683.jpg","datePublished":"2021-06-02T09:50:41+00:00","dateModified":"2025-01-17T10:02:41+00:00","breadcrumb":{"@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#primaryimage","url":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg","contentUrl":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-content\/uploads\/sites\/286\/2021\/05\/Lehtonen-Sarka-1075-scaled.jpg","width":2560,"height":1707,"caption":"Lehtonen Sarka"},{"@type":"BreadcrumbList","@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/sarka-lehtonen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/"},{"@type":"ListItem","position":2,"name":"\u0160\u00e1rka Lehtonen"}]},{"@type":"WebSite","@id":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/#website","url":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/","name":"Lehtonen lab\/ Human Brain Disease Modelling Research Group","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/pages\/661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/users\/575"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/comments?post=661"}],"version-history":[{"count":2,"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/pages\/661\/revisions"}],"predecessor-version":[{"id":4169,"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/pages\/661\/revisions\/4169"}],"wp:attachment":[{"href":"https:\/\/sites.uef.fi\/human-brain-disease-modelling-group\/wp-json\/wp\/v2\/media?parent=661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}